25,405 research outputs found
Measurement of the ratio of prompt χ c to J / ψ production in pp collisions at √s = 7 TeV
No full textThe prompt production of charmonium χ c and J / ψ states is studied in proton-proton collisions at a centre-of-mass energy of √s = 7 TeV at the Large Hadron Collider. The χ c and J / ψ mesons are identified through their decays χ c → J / ψ γ and J / ψ → μ + μ - using 36 pb - 1 of data collected by the LHCb detector in 2010. The ratio of the prompt production cross-sections for χ c and J / ψ, σ (χ c → J / ψ γ) / σ (J / ψ), is determined as a function of the J / ψ transverse momentum in the range 2 < p T J / ψ < 15 GeV / c. The results are in excellent agreement with next-to-leading order non-relativistic expectations and show a significant discrepancy compared with the colour singlet model prediction at leading order, especially in the low p T J / ψ region
A 2 h periodic variation in the low-mass X-ray binary Ser X-1
No full textSpectroscopy of the low-mass X-ray binary Ser X-1 using the Gran Telescopio Canarias have revealed a ?2 h periodic variability that is present in the three strongest emission lines. We tentatively interpret this variability as due to orbital motion, making it the first indication of the orbital period of Ser X-1. Together with the fact that the emission lines are remarkably narrow, but still resolved, we show that a main-sequence K dwarf together with a canonical 1.4 M? neutron star gives a good description of the system. In this scenario, the most likely place for the emission lines to arise is the accretion disc, instead of a localized region in the binary (such as the irradiated surface or the stream-impact point), and their narrowness is due instead to the low inclination (?10°) of Ser X-1
Evidence for the decay B0→J/ψω and measurement of the relative branching fractions of meson decays to J/ψη and J/ψη′
No full textFirst evidence of the B 0 → J / ψ ω decay is found and the B s 0 → J / ψ η and B s 0 → J / ψ η ′ decays are studied using a dataset corresponding to an integrated luminosity of 1.0 fb -1 collected by the LHCb experiment in proton-proton collisions at a centre-of-mass energy of sqrt(s) = 7 TeV. The branching fractions of these decays are measured relative to that of the B 0 → J / ψ ρ 0 decay:frac(B (B 0 → J / ψ ω), B (B 0 → J / ψ ρ 0)) = 0.89 ± 0.19 (stat) - 0.13 + 0.07 (syst),frac(B (B s 0 → J / ψ η), B (B 0 → J / ψ ρ 0)) = 14.0 ± 1.2 (stat) - 1.5 + 1.1 (syst) - 1.0 + 1.1 (frac(f d, f s)),frac(B (B s 0 → J / ψ η ′), B (B 0 → J / ψ ρ 0)) = 12.7 ± 1.1 (stat) - 1.3 + 0.5 (syst) - 0.9 + 1.0 (frac(f d, f s)), where the last uncertainty is due to the knowledge of f d / f s, the ratio of b-quark hadronization factors that accounts for the different production rate of B 0 and B s 0 mesons. The ratio of the branching fractions of B s 0 → J / ψ η ′ and B s 0 → J / ψ η decays is measured to befrac(B (B s 0 → J / ψ η ′), B (B s 0 → J / ψ η)) = 0.90 ± 0.09 (stat) - 0.02 + 0.06 (syst)
Polyomavirus BK-specific cellular immune response in Kidney transplant recipients
No full textPolyomavirus BK is an emerging pathogen in KT recipients. New potent
immunosuppressive drugs promote reactivation and replication of BKV and progression
towards PVAN. PVAN occurs in up to 10% of the KT recipients with a graft loss in up to
80% of the cases. New potent immunosuppressive drugs, as MMF) and FK506 are risk factors
for developing PVAN. As no proven antiviral drugs are available, the only therapy of choice
is the reduction of immunosuppressiva in order to regain BKV-replication control (H. H.
Hirsch, M. Dickenmann, S. Binggeli, J. Steiger, Schweiz Med Forum 2004; 4:538–541).
BKV-specific cellular and humoral immune response is not well characterized. Recent
findings have shown that BKV-seropositive patients prior to transplantation are not protected
from BKV-replication. In contrast, BKV-specific cellular immune response correlates with
the diagnosis of PVAN (P. Comoli, S. Binggeli, F. Ginevri, H. H. Hirsch, Transplant
Infectious Disease Jun 2006; 8(2):86-94, Review).
The aim of this study was to investigate the interplay of BKV-specific immune response
and BKV-replication in blood samples of KT recipients. We examined the BKV-specific
immune response by ELISpot assay in KT. PBMC of KT recipients were stimulated with
BKV LT-antigen and BKV-VP1 peptide libraries. The BKV-specific immune response was
measured by the detection of IFN-γ by ELISpot assay. From the results of a pilot study with
eight patients we were able to deduce that the dynamics of viral-replication rather than the
viral load correlates with a protective immune response (S. Binggeli, A. Egli, M.
Dickenmann, I. Binet, J. Steiger, H. H. Hirsch, American Journal of Transplantation, Sep
2006; 6(9):2218-9).
To corroborate this previous observation the BKV-specific cellular immunity in 42 KT
recipients and 10 HB were tested. The KT patients were divided into two groups: patient
group 1 with an increasing or stable viral load (inc/hi)1 and patient group 2 with a decreasing
viral load or after resolved PVAN (dec)2. Indeed patients in group 2 showed a significantly
higher immune response upon stimulation with BKV-LT and BKV-VP1 than patients in
group 1 (P=0.003, P=0.001, respectively, Wilcoxon, two-sided). Detailed analysis revealed a
cut-off of >69 SFU/Mio PBMC for BKV LT-antigen, but not for BKV VP1, with
significantly more KT patients from group 2 (dec) than from group 1 (inc/hi). This cut-off has
to be validated in a prospective study and also analyzed whether such a cut-off can be used for
immunosuppressive reduction guidance.
BKV-specific cell expansion was tested in a short-term culture in the presence of either
BKV-LT or -VP1. After 9-day culture, PBMC were restimulated with BKV-LT or -VP1 and
the responses were then compared with responses to direct stimulation (without prior
cultivation). BKV-LT and -VP1 specific cellular immune responses were significantly higher
after 9-day cultivation than after direct stimulation (P=0.002, P=0.003, respectively,
Wilcoxon, two sided).
Due to high sequence homology between JCV and BKV, JCV-LT and -VP1 overlapping
peptide pools were used to test PBMC-cross recognition. JCV-LT and -VP1 responses were
significantly lower than BKV-mediated response (P=0.008, P<0.001, respectively, Wilcoxon,
two-sided). Comparison of JCV- and BKV-specific responses after 9-day culture revealed that
the BKV-VP1 response was significantly higher than the JCV-VP1 (P=0.016, Wilcoxon, two
sided), but no significant difference was observed for LT-antigen (S. Binggeli, A. Egli, S.
Schaub, I. Binet, M. Mayr, J. Steiger, H. H. Hirsch, American Journal of Transplantation, Mar
2007; 7:1-9).
Agnoprotein, a late viral protein, is highly expressed upon infection. We investigated
whether agnoprotein is able to induce a BKV-specific immune response and whether it may
serve as a diagnostic marker. Immunostaining revealed that agnoprotein was highly expressed
in the cytoplasm of infected cells and was only seen in combination with BKV-LT which is
located in the nucleus. Interestingly, BKV-agnoprotein specific cellular and humoral immune
responses were scarcely detected in HB or KT recipients. There are only few published
studies concerning BKV-agnoprotein, and further investigations are necessary to fully
understand the function of agnoprotein during infection. (D. Leuenberger, P. A. Andresen, R.
Gosert, S. Binggeli, E. H. Ström, S. Bodaghi, C Hanssen Rinaldo, H. H. Hirsch, Clinical and
Vaccine Immunology, Aug 2007; 14(8): 959-968).
As no antiviral treatment is available for BKV, the only therapy is the reduction of
immunosuppressive drugs in order to regain immunological control over BKV-replication and
PVAN. However reduction of immunosuppressants upon PVAN diagnosis bears the risk of
rejection or inflammatory response to BKV. It is difficult to distinguish between these two
outcomes because specific markers are yet lacking. Therefore, it is pivotal to record the
clinico-pathological course of the KT patient in order to correctly diagnose the problem as the
therapies are completely different. Measuring the BKV-specific cellular immune response
may support and complement other markers, such as PCR analysis and biopsies, to better
distinguish between rejection and BKV-specific immune response. (S. Schaub, M. Mayr, A.
Egli, S. Binggeli, B. Descoeudres, J. Steiger, M. J. Mihatsch, H. H. Hirsch, Nephrology
Dialysis Transplantation, Aug 2007; 22(8): 2386-90).
Finding the optimal immunosuppressive drug level is crucial for preventing rejection
(under-immunosuppressed) and viral replication (over-immunosuppressed). Our current study
showed a cut-off level of 6.65 ng/ml FK506 drug level in blood, dividing those KT patients
with and without BKV-replication control (ROC-curve: AUC=0.897, sensitivity=78%,
specificity=86%). If this cut-off is validated by a well designed prospective study, it may
serve as a guideline to administrate the optimal drug level. (S. Binggeli, 2007, current results).
BKV-specific epitopes have received considerable attention in the last five years. We
started with the epitope mapping in a kidney patient with the most common HLA-type: HLAA*
01, HLA-B*08. First screening of BKV-LT revealed ten 15aa long peptides with
immunogenic potential. Three of these ten peptides were further investigated for crossrecognition
with the homologous JCV-peptides. Even though response to the three JCVpeptides
was lower, cellular immune response could be clearly detected. It needs further
investigation to find more BKV-specific epitopes and also to test the ability of CD8+ T-cells
to kill BKV-antigen presenting cells. (S. Binggeli, 2007, current results)
Catalytic P-H activation by Ti and Zr catalysts
No full textCatalytic dehydrocoupling of phosphines was investigated using the anionic zirconocene trihydride salts [Cp*Zr-2(mu-H)(3)Li](3) (1a) or [Cp*Zr-2(mu-H)(3)K(thf)(4)] (1b), and the metallocycles [CpTi(NPtBu3)(CH2)(4)] (6) and [Cp*M(NPtBu3)(CH2)(4)] (M = Ti 20, Zr 21) as catalyst precursors. Dehydrocoupling of primary phosphines RPH2 (R = Ph, C6H2Me3, Cy, C10H7) gave both dehydrocoupled dimers RP(H)P(H)R or cyclic oligophosphines (RP)(n) (n = 4, 5) while reaction of tBu(3)C(6)H(2)PH(2) gave the phosphaindoline tBu(2)(Me2CCH2)C6H2PH (9). Stoichiometric reactions of these catalyst precursors with primary phosphines afforded [Cp*Zr-2((PR)(2))H][K(thf)(4)] (R = Ph 2, Cy 3, C6H2Me3 4), [Cp*Zr-2((PPh)(3))H] [K(thf)(4)] (5), [CpTi(NPtBu3)(PPh)(3)] (7) and [CpTi(NPtBu3)(mu-PHPh)](2) (8), while reaction of 6 with (C(6)H(2)tBu3)PH2 in the presence of PMe3 afforded [CpTi(NPtBu3)(PMe3)(p(C(6)H(2)tBu(3))] (10). The secondary phosphines Ph2PH and (PhHPCH2)(2)CH2 also undergo dehydrocoupling affording (Ph2P)(2) and (PhPCH2)(2)CH2. The bisphosphines (CH2PH2)(2) and C6H4(PH2)(2) are dehydrocoupled to give (PCH2CH2PH)(2) (12) and (C6H4P(PH))(2) (13) while prolonged reaction of 13 gave (C6H4P2)(8) (14). The analogous bisphosphine Me2C6H4(PH)(2) (17) was prepared and dehydrocoupling catalysis afforded (Me2C6H2P(PH))(2) (18) and subsequently [(Me2C6H2P2)(2)(mu-Me2C6H2P2)](2) (19). Stoichiometric reactions with these bisphosphines gave [Cp*Zr-2(H)(PH)(2)C6H4] [Li(thf)(4)] (22), [Cp*Ti(NPtBu3)(PH)(2)C6H4](2) (23) and [Cp*Ti(NPtBu3)(PH)(2)C6H4] (24). Mechanistic implications are discussed.PT: J; CR: ALBRAND JP, 1976, J CHEM SOC CHEM COMM, P876 ANSELME JP, 1969, TETRAHEDRON, V25, P855 BASULI F, 2003, J AM CHEM SOC, V125, P10170 BAUDLER M, 1976, Z NATURFORSCH B, V31, P558 BAUDLER M, 1978, CHEM BER, V111, P1210 BAUDLER M, 1978, CHEM BER, V111, P1217 BAUDLER M, 1983, CHEM BER, V116, P2711 BAUDLER M, 1984, Z NATURFORSCH B, V39, P438 BAZAN GC, 1991, J AM CHEM SOC, V113, P6899 BOHM VPW, 2001, ANGEW CHEM, V113, P4832 CHAUVIN Y, 1971, MAKROMOL CHEM, V141, P161 COREY JY, 2004, ADV ORGANOMET CHEM, V51, P1 COURET C, 1986, ORGANOMETALLICS, V5, P113 COWLEY AH, 1984, TETRAHEDRON LETT, V25, P2125 COWLEY AH, 1990, INORG SYNTH, V27, P235 CROMER DT, 1974, INT TABLES CRYSTALLO, V4, P71 ETKIN N, 1997, J AM CHEM SOC, V119, P11420 ETKIN N, 1997, J AM CHEM SOC, V119, P2954 ETKIN N, 1997, ORGANOMETALLICS, V16, P3504 FEHLNER TP, 1992, INORGANOMETALLLICS FERMIN MC, 1995, J AM CHEM SOC, V117, P12645 FERMIN MC, 1995, ORGANOMETALLICS, V14, P4247 FU GC, 1993, J AM CHEM SOC, V115, P9856 GAUVIN F, 1998, ADV ORGANOMET CHEM, V42, P363 GRAHAM TW, 2004, ORGANOMETALLICS, V23, P3309 GRUBBS RH, 1972, J AM CHEM SOC, V94, P2538 GRUBBS RH, 2003, HDB METATHESIS HEY E, 1988, CHEM BER, V121, P561 HEY E, 1989, J ORGANOMET CHEM, V378, P375 HO JW, 1991, ORGANOMETALLICS, V10, P3001 HO JW, 1994, INORG CHEM, V33, P865 HOFFMAN PR, 1975, INORG CHEM, V14, P1997 HOSKIN AJ, 2001, ANGEW CHEM, V113, P1917 HOU ZM, 1993, ORGANOMETALLICS, V12, P3158 INAGAKI Y, 1980, B CHEM SOC JPN, V53, P205 ISSLEIB K, 1972, ANGEW CHEM, V84, P582 ISSLEIB K, 1987, J ORGANOMET CHEM, V330, P17 JACOBSEN EN, 1988, J AM CHEM SOC, V110, P1968 KATSUKI T, 1980, J AM CHEM SOC, V102, P5974 KAUFFMANN T, 1984, TETRAHEDRON LETT, V25, P1963 KAUFFMANN T, 1985, CHEM BER, V118, P1022 KITAMURA M, 1988, J AM CHEM SOC, V110, P629 KNOWLES WS, 1983, ACCOUNTS CHEM RES, V16, P106 KOEPF H, 1981, CHEM BER, V114, P2731 KOHLER EP, 1935, J AM CHEM SOC, V57, P367 KYBA EP, 1983, ORGANOMETALLICS, V2, P1877 MILLER AR, 1976, J AM CHEM SOC, V98, P1860 MILLER SJ, 1996, J AM CHEM SOC, V118, P9606 MIYASHITA A, 1980, J AM CHEM SOC, V102, P7932 MURDZEK JS, 1987, ORGANOMETALLICS, V6, P1373 NGUYEN ST, 1992, J AM CHEM SOC, V114, P3974 NGUYEN ST, 1993, J AM CHEM SOC, V115, P9858 NOVAK BM, 1988, J AM CHEM SOC, V110, P960 OHKUMA T, 1995, J AM CHEM SOC, V117, P2675 OHTA T, 1988, INORG CHEM, V27, P566 OSHIKAWA T, 1985, CHEM IND-LONDON, P126 ROCKLAGE SM, 1981, J AM CHEM SOC, V103, P1440 SCHOLL M, 1999, TETRAHEDRON LETT, V40, P2247 SCHROCK RR, 1974, J AM CHEM SOC, V96, P6796 SCHROCK RR, 1980, J MOL CATAL, V8, P73 SCHROCK RR, 1988, J MOL CATAL, V46, P243 SCHROCK RR, 1990, J AM CHEM SOC, V112, P3875 SCHWAB P, 1995, ANGEW CHEM INT EDIT, V34, P2039 SCHWAB P, 1995, ANGEW CHEM, V107, P2179 SCHWAB P, 1996, J AM CHEM SOC, V118, P100 SENDERIKHIN AI, 1988, ZH OBSHCH KHIM+, V58, P1662 SENDERIKHIN AI, 1989, ZH OBSHCH KHIM+, V59, P2141 SEYFERTH D, 1969, J ORG CHEM, V34, P1483 SHELDRICK GM, 2000, SHELXTL SHU RH, 1998, J AM CHEM SOC, V120, P12988 SMIT CN, 1983, TETRAHEDRON LETT, V24, P2031 SOUFFLET JP, 1973, CR ACAD SCI C CHIM, V276, P169 STEPHAN DW, 2000, ANGEW CHEM, V112, P322 STEPHAN DW, 2005, ORGANOMETALLICS, V24, P2548 STRADIOTTO M, 2001, HELV CHIM ACTA, V84, P2958 TILLEY TD, 1990, COMMENTS INORG CHEM, V10, P37 TILLEY TD, 1993, ACCOUNTS CHEM RES, V26, P22 TVERDOMED SN, 2003, RUSS J GEN CHEM+, V73, P319 VANDENWINKEL Y, 1991, J ORGANOMET CHEM, V405, P183 WATERMAN R, 2006, ANGEW CHEM INT EDIT, V45, P2926 WATERMAN R, 2006, ANGEW CHEM, V118, P2992 WEAST RC, 1974, HDB CHEM PHYS, P2436 WOOD CD, 1979, J AM CHEM SOC, V101, P3210 WU Z, 1995, J AM CHEM SOC, V117, P5503 XIN SX, 1997, J AM CHEM SOC, V119, P5307; NR: 85; TC: 0; J9: CHEM-EUR J; PG: 12; GA: 113PJSource type: Electronic(1
Rearrangement of alkylchlorocarbenes: 1,2-H shift in free carbene, carbene-olefin complex, and excited states of carbene precursors
No full textPhotolysis of alkylchlorodiazirines (1) in the presence of olefins gives a cyclopropane (3) by addition of the generated carbene to the olefin and a vinyl chloride derivative (2) resulting from a 1,2-H shift rearrangement. This rearrangement may occur either in the carbene or in some excited state, precursor of the carbene (RIES mechanism), or in a ''carbene + olefin complex'' on the way to the formation of 3 (COC mechanism). Results obtained by time-resolved photoacoustic calorimetry as well as by thermolysis and photolysis of ClCH2C(N-2)Cl and CH3(CH2)(2)C(N-2)Cl in the presence of tetramethylethylene clearly indicate that both the RIES and COC mechanisms play a role but with efficiencies which greatly depend on the nature of the diazirine. Reexamination of the results previously obtained with benzylchlorodiazirines indicates that, for this class of diazirines, the RIES mechanism is temperature dependent and has a very low efficiency at room temperature and below, whereas the nonlinearity of the plots [3]/[2] vs [olefin] is mainly due to the COC mechanism.PT: J; CR: BIGOT B, 1978, J AM CHEM SOC, V100, P8575 CHANG KT, 1979, J AM CHEM SOC, V101, P5082 FREY HM, 1966, ADV PHOTOCHEM, V4, P225 GANZER GA, 1986, J AM CHEM SOC, V108, P1517 GRAHAM WH, 1965, J AM CHEM SOC, V87, P4396 HEIHOFF K, 1987, BIOCHEMISTRY-US, V22, P1422 HOUK KN, 1984, J AM CHEM SOC, V106, P4291 HOUK KN, 1984, J AM CHEM SOC, V106, P4293 JACKSON JE, 1994, ADV CARBENE CHEM, V1 KANABUSKAMINSKA JM, 1987, J AM CHEM SOC, V109, P5267 LAVILLA JA, 1989, J AM CHEM SOC, V111, P6877 LAVILLA JA, 1989, J AM CHEM SOC, V111, P712 LAVILLA JA, 1990, TETRAHEDRON LETT, V31, P5109 LIU MTH, 1987, J ORG CHEM, V52, P4223 LIU MTH, 1989, J CHEM SOC CHEM COMM, P12 LIU MTH, 1990, J AM CHEM SOC, V112, P3915 MODARELLI DA, 1991, J AM CHEM SOC, V113, P8985 MODARELLI DA, 1992, J AM CHEM SOC, V114, P7034 MOSS RA, 1993, J CHEM SOC CHEM COMM, P1597 MOSS RA, 1994, ADV CARBENE CHEM, V1 MULDER P, 1988, J AM CHEM SOC, V110, P4090 MULLERREMMERS PL, 1985, J AM CHEM SOC, V107, P7275 NI T, 1989, J AM CHEM SOC, V111, P457 NICKON A, 1993, ACCOUNTS CHEM RES, V26, P84 RUDZKI JE, 1985, J AM CHEM SOC, V107, P7849 SKELL PS, 1969, J AM CHEM SOC, V91, P7131 TOMIOKA H, 1984, J AM CHEM SOC, V106, P454 TURRO NJ, 1982, J AM CHEM SOC, V104, P1754 WARNER PM, 1984, TETRAHEDRON LETT, V25, P4211 WESTRICK JA, 1987, BIOCHEMISTRY-US, V26, P8313 WHITE WR, 1992, J ORG CHEM, V57, P2841 WIERLACHER S, 1993, J AM CHEM SOC, V115, P8943 YAMAMOTO N, 1994, J AM CHEM SOC, V116, P2064; NR: 33; TC: 30; J9: J AMER CHEM SOC; PG: 9; GA: UG695Source type: Electronic(1
Mesophilic-hydrothermal-thermophilic (M-H-T) digestion of green corn straw
No full textMesophilic-hydrothermal (80-160 degrees C, 30 min)-thermophilic (M-H-T) digestion and control tests of mesophilic (M), thermophilic (T), hydrothermal-mesophilic (H-M), and mesophilic-thermophilic digestion (M-T) of green corn straw were conducted for a 20-day fermentation period. The results indicate that M-H-T is an efficient method to improve methane production. A maximum methane yield of 371.74 mL/g volatile solid was obtained by the M (3 days)-H (140 degrees C)-T (17 days) process, which was 20.44%, 16.55%, 31.44%, and 14.31% higher than the yields of the M, T, 140-M, and M-T processes. The enhanced methane production was attributed to (1) the improved hemicellulose degradation and lignin disorganization; (2) prevention of the degradation of soluble sugar, easily hydrolyzed hemicellulose and cellulose into furfural and methylfurfural; and (3) lack of formation of Maillard reaction products during initial hydrothermal treatment. (C) 2015 Elsevier Ltd. All rights reserved
1, 2-H shift in benzylchlorocarbene: isotope effect and influence of the solvent
No full textLaser flash photolysis of 3-chloro-3-benzyldiazirine and 3-chloro-3-(phenyldideuteriomethyl)diazirine in isooctane over the 60 to -80-degrees-C temperature range gives rise to curved Arrhenius plots for both 1,2-H and 1,2-D migration in benzylchlorcarbene. The k(H)/k(D) values increase smoothly from 0.87 to 2.62 when the temperature increases from -60 to +30-degrees-C. The k(H)/k(D) value is approximately 4 for most of the temperatures studied if a solvent correction is applied. Quantum mechanical tunnelling or the influence of the solvent may be a possible explanation for these observations.PT: J; CR: BONNEAU R, 1989, J AM CHEM SOC, V111, P5973 BONNEAU R, 1992, J PHOTOCH PHOTOBIO A, V68, P97 DIX EJ, 1993, J AM CHEM SOC, V115, P10424 EVANSECK JD, 1990, J PHYS CHEM-US, V94, P5518 GRAHAM WH, 1965, J AM CHEM SOC, V87, P4396 JACKSON JE, 1994, ADV CARBENE CHEM JONES M, 1980, REACTIVE INTERMEDIAT, V2 KIRMSE W, 1971, CARBENE CHEM LIU MTH, 1984, TETRAHEDRON, V40, P887 LIU MTH, 1990, J AM CHEM SOC, V112, P3915 LIU MTH, 1992, J PHOTOCH PHOTOBIO A, V63, P115 LIU MTH, 1992, J PHYS ORG CHEM, V15, P285 LIU MTH, 1994, RES CHEM INTERMEDIAT, V20, P195 MODARELLI DA, 1992, J AM CHEM SOC, V114, P7034 MOSS RA, 1992, TETRAHEDRON LETT, V33, P4287 MOSS RA, 1994, ADV CARBENE CHEM MUROV SL, 1973, HDB PHOTOCHEMISTRY NICKON A, 1993, ACCOUNTS CHEM RES, V26, P84 SALIS GA, 1968, J PHYS CHEM-US, V72, P752 SANDER W, 1994, UNPUB SCHAEFER HF, 1979, ACCOUNTS CHEM RES, V12, P288 SCHOLLER WW, 1989, HOUBEN WEYL METHODEN, P41 SHIMANOUCHI T, 1972, TABLES MOL VIBRATION, V1 SUGIYAMA MH, 1992, J AM CHEM SOC, V114, P966 WIERLACHER S, 1993, J AM CHEM SOC, V115, P8943; NR: 25; TC: 20; J9: J PHOTOCHEM PHOTOBIOL A-CHEM; PG: 5; GA: PV021Source type: Electronic(1
Time-resolved-absorption spectroscopic detection of 10,10-dimethyl-10-silaanthracen-9(10H)-one oxide
No full textPT: J; CR: ANDO W, 1981, J SYN ORG CHEM JPN, V39, P613 BARTLETT PD, 1962, J AM CHEM SOC, V84, P3408 HAYASHI H, 1980, B CHEM SOC JPN, V53, P1519 KANAMARU N, 1970, B CHEM SOC JPN, V43, P3443 MURRAY RW, 1971, J AM CHEM SOC, V93, P4963 SAWAKI Y, 1981, J AM CHEM SOC, V103, P3832 SEKIGUCHI A, 1982, TETRAHEDRON LETT, V23, P4095 STEWART R, 1963, CAN J CHEM, V41, P1065 SUGAWARA T, 1983, CHEM LETT TURRO NJ, 1980, IEEE J QUANTUM ELECT, V16, P1218; NR: 10; TC: 47; J9: CHEM LETT; PG: 2; GA: RB995Source type: Electronic(1
Determination of the photolytic decomposition pathways of benzylchlorodiazirine by C60 probe technique
No full textBy employing C-60 as a chemical probe, the photolysis of benzylchlorodiazirine has been proposed to form carbene and the rearranged products via the excited state. (c) 2006 Elsevier Ltd. All rights reserved.PT: J; CR: AKASAKA T, 1999, ORG LETT, V1, P1509 AKASAKA T, 2000, J AM CHEM SOC, V122, P7134 FREY HM, 1965, J CHEM SOC, P1700 GRAHAM WH, 1965, J AM CHEM SOC, V87, P4396 HIRSCH A, 1993, CHEM BER, V126, P1061 ISHITSUKA MO, 2004, TETRAHEDRON LETT, V45, P6321 KORSHUNOVA GA, 2000, MOL BIOL+, V34, P823 LIU MTH, 1985, J CHEM SOC CHEM COMM, P982 LIU MTH, 1987, CHEM DIAZIRINES, V1 LIU MTH, 1987, CHEM DIAZIRINES, V2 LIU MTH, 1990, J AM CHEM SOC, V112, P3915 LIU MTH, 1992, J AM CHEM SOC, V114, P3604 LIU MTH, 2003, J ORG CHEM, V68, P7471 MODARELLI DA, 1992, J AM CHEM SOC, V114, P7034 NIGAM M, 1998, J AM CHEM SOC, V120, P8055 RICHARDS FM, 2000, PROTEIN SCI, V9, P2506 TOMIOKA H, 1984, J AM CHEM SOC, V106, P454 WAKAHARA T, 2002, J AM CHEM SOC, V124, P9465; NR: 18; TC: 0; J9: TETRAHEDRON LETT; PG: 3; GA: 130SPSource type: Electronic(1
- …
